- Addresses the need to reduce premature infants' hospital stay
- Enables clinicians additional options to address infants' inability to feed
Laurel, MARYLAND, September 7, 2011 ― GE Healthcare, Inc. (NYSE: GE) and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division (MIC) exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system in the U.S.